Ballerup, Denmark

Yi He

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Nordic Bioscience A/s. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi He. Retrieved from https://idiyas.com/inventor/yi-he-j8nkya5w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yi He: Innovator in Collagen Research

Introduction

Yi He is a prominent inventor based in Ballerup, Denmark. He has made significant contributions to the field of collagen research, particularly in the development of immunoassays for evaluating diseases associated with collagen type X alpha 1.

Latest Patents

Yi He holds 2 patents related to collagen type X alpha 1. His latest patents include an antibody specifically reactive with an N-terminus neo-epitope of collagen type X alpha 1, which is useful in an immunoassay for evaluating diseases such as osteoarthritis. Another patent involves an antibody reactive with an epitope in the NC1 domain C-terminal amino acid sequence of collagen type X alpha 1, facilitating the detection of this epitope in biological samples.

Career Highlights

Yi He is currently associated with Nordic Bioscience A/S, where he continues to advance research in collagen-related diseases. His work has been instrumental in developing innovative diagnostic tools that can improve patient outcomes.

Collaborations

He collaborates with notable colleagues such as Morten A Karsdal and Anne Christine Bay-Jensen, contributing to a dynamic research environment focused on collagen and its implications in various diseases.

Conclusion

Yi He's contributions to collagen research and his innovative patents highlight his role as a key inventor in the field. His work continues to pave the way for advancements in medical diagnostics and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…